The Role of Transforming Growth Factor-Beta in Diabetic Nephropathy (Q59048778)

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

The role of inflammatory cytokines in diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Gene polymorphism of transforming growth factor-β1 in Egyptian patients with type 2 diabetes and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Plasma interleukin-6, tumour necrosis factor alpha and blood cytokine production in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes: the Whitehall II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Chronic inflammation links cardiovascular, metabolic and renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Transcriptional control by the TGF-beta/Smad signaling system

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Transforming growth factor-beta and Smad signalling in kidney diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Natural inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Transforming growth factor beta activity in urine of patients with type 2 diabetes and diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

IκBζ regulates TH17 development by cooperating with ROR nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Inhibition of TGF-beta expression: a novel role for thiazolidinediones to implement renoprotection in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Thiazolidinediones provide better renoprotection than insulin in an obese, hypertensive type II diabetic rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Thiazolidinedione ameliorates renal injury in experimental diabetic rats through anti-inflammatory effects mediated by inhibition of NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

A catalog of 106 single-nucleotide polymorphisms (SNPs) and 11 other types of variations in genes for transforming growth factor-beta1 (TGF-beta1) and its signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Intron-exon structure of the human transforming growth factor-beta precursor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Common variants of inflammatory cytokine genes are associated with risk of nephropathy in type 2 diabetes among Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Association of transforming growth factor-beta (TGF-beta) T869C (Leu 10Pro) gene polymorphisms with type 2 diabetic nephropathy in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Association of polymorphisms within the transforming growth factor-β1 gene with diabetic nephropathy and serum cholesterol and triglyceride concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Hypercholesterolemia leads to elevated TGF-beta1 activity and T helper 3-dependent autoimmune responses in atherosclerotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Association between the T869C polymorphism of transforming growth factor-beta 1 and diabetic nephropathy: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

IHG-1 amplifies TGF-β1 signalling and mitochondrial biogenesis and is increased in diabetic kidney disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270

Both ERK/MAPK and TGF-Beta/Smad signaling pathways play a role in the kidney fibrosis of diabetic mice accelerated by blood glucose fluctuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2014%2F180270